Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Joslin Scientists Find That Salsalate… >

Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 Diabetes

Published: July 2, 2013.
Released by Joslin Diabetes Center  

BOSTON – July 1, 2013 -- Joslin scientists report that salsalate, a drug used to treat arthritis, lowers blood glucose and improves glycemic control in type 2 diabetes. These findings, which were published today by the Annals of Internal Medicine, provide additional evidence that salsalate may be an effective drug to treat type 2 diabetes.

The scientists became interested in studying salsalate, an anti-inflammatory drug, after research conducted by Steven Shoelson, M.D., Ph.D., Head of the Section on Pathophysiology and Molecular Pharmacology and Professor of Medicine at Harvard Medical School, identified inflammation as a factor in the development of type 2 diabetes.

Stage 1 of TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) evaluated varying doses of salsalate in 108 participants with type 2 diabetes for 14 weeks. This study was reported in the Annals of Internal Medicine in 2010. The current findings are based on Stage 2 of TINSAL-T2D, which evaluated 286 participants with type 2 diabetes for 48 weeks. The subjects' blood glucose was inadequately controlled on current diabetes medications. Participants were randomized into salsalate and placebo groups.

After 48 weeks of treatment, the mean hemoglobin A1c level (a measurement of average blood glucose control over the past six to twelve weeks) was 37 percent lower in the salsalate group compared to the placebo group. The decrease in fasting glucose concentration was 15 mg/dl greater in the salsalate group than the placebo group. Patients in the salsalate group required fewer additional diabetes medications to control their blood sugar than patients in the placebo group.

"It's exciting that salsalate is effective in lowering blood sugar," says Allison Goldfine, M.D., lead author and Head of the Section of Clinical, Behavioral and Outcomes Research, and an Associate Professor of Medicine at Harvard Medical School. "Salsalate may have an important role in diabetes treatment and may also help us learn more about how inflammation contributes to the development of type 2 diabetes."

The salsalate group also showed improvements in markers associated with coronary risk: a 9 percent reduction in triglycerides and a 27 percent increase in adiponectin, a potentially cardioprotective protein from adipocytes. Uric acid, which is associated with cardiometabolic conditions and progression of renal disease, decreased 18 percent in the salsalate group. "The reductions in these cardiovascular risk factors paralleled improved glycemia," says Dr. Goldfine. However, the salsalate group also exhibited modest increases in LDL cholesterol and urine albumin, and had a slight increase in weight, which can indicate negative effects on heart or kidney function.

Salsalate's anti-inflammatory effects were evidenced by reductions in circulating white blood cells, neutrophils and lymphocytes, which are elevated in obesity and metabolic syndrome, but all remained within normal range.

The next step in determining whether salsalate is a safe drug for use as a diabetes medication and can receive FDA approval is to assess its effects on the progression of heart disease. Dr. Goldfine is currently leading a study, TINSAL-CVD, which is evaluating how salsalate affects coronary artery plaque volume in participants with established coronary artery disease. The results should be available in two years. "The study will help us better understand the risk/benefit ratio of using salsalate to treat diabetes," says Dr. Goldfine.




The above story is based on materials provided by Joslin Diabetes Center.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Disease 
12/3/13 
International Study Finds Heart Disease Similar in Men And Women
CHICAGO – An analysis of data from an international multicenter study of coronary computed tomography angiography (CCTA) reveals that …
Patients 
12/2/14 
Even Mild Coronary Artery Disease Puts Diabetic Patients at Risk
CHICAGO - According to a new long-term study, diabetic patients with even mild coronary artery disease face the same …
Plaque 
4/22/14 
CT Measures Potentially Dangerous Arterial Plaque in Diabetic Patients
OAK BROOK, Ill. – Imaging of the coronary arteries with computed tomography (CT) angiography provides an accurate assessment of …
Significant 
6/7/10 
Cardiac Imaging Breakthrough Helps Determine Diminished Blood Flow to the Heart
SALT LAKE CITY—Research presented at SNM's 57th Annual Meeting is challenging the typical paradigm used to determine whether heart …
Ccta 
3/26/12 
Penn Study Reveals Safety of CT Scans for Rapid Rule Out of Heart Attacks in ER Chest Pain Patients
A highly detailed CT scan of the heart can safely and quickly rule out the possibility of a heart …
High-Risk 
11/4/14 
Study Finds Association Between Coronary Artery Plaque And Liver Disease
OAK BROOK, Ill. – Researchers using coronary computed tomography angiography (CCTA) have found a close association between high-risk coronary …
Risk 
2/19/13 
CT Angiography Helps Predict Heart Attack Risk
OAK BROOK, Ill. – Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart …
Plaque 
8/16/11 
Fat Around Heart May Be Early Indicator of Coronary Disease
OAK BROOK, Ill. – Researchers have found more evidence supporting the role of fat around the heart in promoting …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile